Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Gianluca Gaïdano, Pietro Bulian et al.|Blood|2015Cited by 215
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Marco Ladetto, Simone Ferrero et al.|Cancers|2021Cited by 13
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low‐risk chronic lymphocytic leukaemia patientsGian Matteo Rigolin, Antonio Cuneo, Alice Traversa et al.|British Journal of Haematology|2023Cited by 2